T. Rowe Price Associates
BCAX

T. Rowe Price Associates’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

T. Rowe Price Associates’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$20M Buy
2,150,310
+352,289
+20% +$3.27M ﹤0.01% 958
2025
Q1 		$23.4M Buy
1,798,021
+250,841
+16% +$3.27M ﹤0.01% 917
2024
Q4 		$27M Buy
1,547,180
+8,246
+0.5% +$144K ﹤0.01% 919
2024
Q3 		$39.2M Buy
+1,538,934
New +$39.2M ﹤0.01% 816